Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction

The American Journal of Cardiology
M KosugeM Ishii

Abstract

In 10 patients with uncomplicated anterior acute myocardial infarction, within 24 hours after onset, heart rate, plasma renin activity, and the low- to high-frequency power ratio increased and high-frequency power decreased during nitroglycerin infusion; however, both heart rate and plasma renin activity did not change, the low- to high-frequency power ratio decreased, and high-frequency power increased during atrial natriuretic peptide infusion. Atrial natriuretic peptide seems to be more beneficial in its effect on autonomic nervous activity, plasma renin activity, and myocardial oxygen consumption than nitroglycerin for the treatment of anterior acute myocardial infarction.

References

Dec 1, 1989·Circulation Research·B ForemanR J Bache
Mar 17, 1986·Life Sciences·C W XieJ Tang
Mar 27, 1986·The New England Journal of Medicine·P Needleman, J E Greenwald
May 1, 1986·Circulation Research·B J Ballermann, B M Brenner
Apr 15, 1985·Life Sciences·R PallukW Hoefke
May 1, 1984·International Journal of Cardiology·R Schröder
May 27, 1995·Lancet·W R Herzog
Jul 16, 1994·Lancet·D G Julian

❮ Previous
Next ❯

Citations

Apr 5, 2001·Journal of Clinical Pharmacy and Therapeutics·J Venugopal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.